CompletedNot Applicable

Predicting the Development of Myocardial Depression in Acute Neurological Patients

United States4 participantsStarted 2018-12-03

Plain-language summary

The purpose of this study is to assess the levels of serum catecholamines associated with myocardial depression (MD) in patients with acute neurological injury.

Who can participate

Age range50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * female patients \>50 years admitted to the neuro ICU with diagnosis of either acute ischemic stroke or subarachnoid hemorrhage * Only patients predicted to be on norepinephrine infusion for at least 48 hrs will be selected. Exclusion Criteria: * patients with known history of heart failure will be excluded * Patients with history of coronary artery disease, smoking, poorly controlled diabetes with HbA1c \>8 and uncontrolled hypertension will be excluded. * Patients with poor ECHO windows will be excluded

What they're measuring

Association of plasma catecholamine levels with stress induced cardiomyopathy

Timeframe: up to 5 days

Association of troponin levels with stress induced cardiomyopathy

Timeframe: up to 5 days

Trial details

NCT IDNCT03801694

SponsorOhio State University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-14

View on ClinicalTrials.gov More Myocardial Depression trials